FDA Weighs COVID Vaccine Composition
FDA advisers to discuss COVID vaccine composition for 2026-2027, potentially impacting vaccine makers' stocks. Decision may affect vaccine efficacy and demand.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FDA advisers to discuss COVID vaccine composition for 2026-2027, potentially impacting vaccine makers' stocks. Decision may affect vaccine efficacy and demand.